This article has been updated to reflect Friday's rise in Caliper's stock price.
NEW YORK (GenomeWeb News) – Shares of Caliper Life Sciences rose around 16 percent on Friday, following a drop of 21 percent on Thursday.
Caliper's shares had fallen sharply a day after the firm reported a 4 percent decline in second-quarter revenues and an analyst said his revenue outlook for the year was below the firm’s guidance.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.